Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
| Product: | Bupivacaine-Baxter |
| Active Ingredient: | Bupivacaine hydrochloride monohydrate 2.5mg/mL |
| Dosage Form: | Solution for injection |
| New Zealand Sponsor: | Baxter Healthcare Limited |
| Manufacturer: | Claris Injectables Limited, Ahmedabad, India |
| Product: | Bupivacaine-Baxter |
| Active Ingredient: | Bupivacaine hydrochloride monohydrate 5mg/mL |
| Dosage Form: | Solution for injection |
| New Zealand Sponsor: | Baxter Healthcare Limited |
| Manufacturer: | Claris Injectables Limited, Ahmedabad, India |
Dated this 21st day of August 2019.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).